Sai Life Sciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	16,946	14,652	12,171	8,696	7,599
Revenue Growth (YoY)	15.66%	20.38%	39.97%	14.44%	-
Cost of Revenue	4,658	4,845	4,667	3,092	2,451
Gross Profit	12,288	9,807	7,505	5,603	5,147
Selling, General & Admin	5,491	5,000	4,235	3,154	2,325
Other Operating Expenses	2,740	1,828	1,546	1,229	1,157
Operating Expenses	9,617	8,085	6,844	5,292	4,280
Operating Income	2,671	1,722	660.66	311.18	867.87
Interest Expense	-761.64	-859.1	-770.57	-495.71	-303.23
Interest & Investment Income	-	135.97	106.64	70.5	82.75
Currency Exchange Gain (Loss)	-	146.26	173.02	97.84	158.35
Other Non Operating Income (Expenses)	367.79	8.58	-	-	-
EBT Excluding Unusual Items	2,277	1,154	169.75	-16.19	805.73
Gain (Loss) on Sale of Assets	-	0.1	-5.67	113.14	-18.33
Asset Writedown	-	-61.86	-	-	-
Other Unusual Items	-	-	-	-	31.79
Pretax Income	2,277	1,092	164.08	96.95	819.19
Income Tax Expense	575.71	264.25	64.19	34.69	208.18
Net Income	1,701	828.09	99.89	62.26	611.01
Net Income to Common	1,701	828.09	99.89	62.26	611.01
Net Income Growth	105.45%	729.00%	60.44%	-89.81%	-
Shares Outstanding (Basic)	193	181	181	180	169
Shares Outstanding (Diluted)	198	183	182	182	172
Shares Change (YoY)	8.04%	0.27%	0.46%	5.32%	-
EPS (Basic)	8.83	4.57	0.55	0.35	3.61
EPS (Diluted)	8.61	4.53	0.55	0.34	3.54
EPS Growth	90.07%	723.64%	61.77%	-90.41%	-
Free Cash Flow	-552.35	813.97	1,063	-1,020	-2,985
Free Cash Flow Per Share	-2.79	4.45	5.83	-5.62	-17.31
Gross Margin	72.51%	66.93%	61.66%	64.44%	67.74%
Operating Margin	15.76%	11.76%	5.43%	3.58%	11.42%
Profit Margin	10.04%	5.65%	0.82%	0.72%	8.04%
Free Cash Flow Margin	-3.26%	5.56%	8.74%	-11.73%	-39.28%
EBITDA	4,057	2,454	1,261	916.14	1,346
EBITDA Margin	23.94%	16.75%	10.36%	10.54%	17.71%
D&A For EBITDA	1,386	731.35	600.8	604.96	478.29
EBIT	2,671	1,722	660.66	311.18	867.87
EBIT Margin	15.76%	11.76%	5.43%	3.58%	11.42%
Effective Tax Rate	25.28%	24.19%	39.12%	35.78%	25.41%
Revenue as Reported	17,313	14,943	12,451	8,977	7,872
Advertising Expenses	-	30.45	11.14	51.05	-

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.